Condition: ICAS - Intracranial Atherosclerosis · Stroke Ischemic · Hemodynamic · Sponsor: Xuanwu Hospital, Beijing
Intracranial atherosclerotic stenosis (ICAS) carries substantial stroke risk despite optimal medical treatment. Current risk stratification relies primarily on stenosis severity, but novel hemodynamic markers may improve prediction. In this multiple prospective registry study we aim to investigate whether regional hemodynamics, measured by a novel Magnetic resonance imaging-derived Pressure Ratio (MPR) technique, are associated with stroke risk in ICAS.
This description comes directly from the study's public registry record.
Jichang Luo, M.D. · +86 13120136577 · luojichang_dr@sina.com
Always discuss trial participation with your own doctor first.
| Department of Neurosurgery, Xuanwu hospital | Beijing, Xicheng District, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07309718